Cargando…
In Peritoneal Dialysis, Is There Sufficient Evidence to Make “PD First” Therapy?
Since its introduction more than 3 decades ago, the use of peritoneal dialysis (PD) has increased greatly due to its simplicity, convenience, and low cost. Advances in technique, antibiotic prophylaxis, and the introduction of newer solutions have improved survival, quality of life, and reduced rate...
Autores principales: | Dalal, Pranav, Sangha, Harbaksh, Chaudhary, Kunal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139118/ https://www.ncbi.nlm.nih.gov/pubmed/21776392 http://dx.doi.org/10.4061/2011/239515 |
Ejemplares similares
-
Peritoneal Dialysis Drop-out: Causes and Prevention Strategies
por: Chaudhary, Kunal
Publicado: (2011) -
Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD
por: Bartosova, Maria, et al.
Publicado: (2019) -
Anti-fibrotic effect of decorin in peritoneal dialysis and PD-associated peritonitis
por: Jiang, Na, et al.
Publicado: (2020) -
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022) -
Evidence on continuous flow peritoneal dialysis: A review
por: de Vries, Joost C., et al.
Publicado: (2022)